Acadia PharmaceuticalsACAD

那斯達克 · USD
26.76
+0.47
(+1.79%)
收盤 01/22 04:59 (UTC+8)
盤後 
26.99 
+0.23 
(+0.86%)
01/22 04:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 1.65
  • 2.12
  • 2.31
  • 2.06
  • 2.42
  • 2.50
  • 2.60
  • 2.44
  • 2.65
  • 2.79
icon
  • 39.48
  • 28.12
  • 9.14
  • -10.91
  • 17.55
  • 3.49
  • 3.67
  • -5.89
  • 8.29
  • 5.32
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
278,634
264,565
244,317
259,602
250,401
241,963
205,831
231,041
211,699
165,235
營業成本
21,64720,73420,39221,80318,85718,23022,95117,89114,6217,459
營業毛利
256,987
243,831
223,925
237,799
231,544
223,733
182,880
213,150
197,078
157,776
營業費用
221,230211,458204,635--193,296-178,206254,854154,739
研發費用
87,82977,95178,265100,73166,60676,23359,67966,741156,96358,771
推銷及管理費用
133,401133,507126,370-16,435133,294117,063107,991111,46597,89195,968
非經常性項目費用
----------
其他營業費用
----------
營業利益
35,757
32,373
19,290
153,503
31,644
30,437
15,210
34,944
-57,776
3,037
其他收入及費用
8,8387,8388,4897,5827,1626,7455,7924,7595,6333,306
利息費用
----------
稅前純益
44,595
40,211
27,779
161,085
38,806
37,182
21,002
39,703
-52,143
6,343
所得稅
-27,18413,5458,79217,3436,0413,7934,447-6,09413,0335,229
稅後純益
71,779
26,666
18,987
143,742
32,765
33,389
16,555
45,797
-65,176
1,114
基本每股稅後盈餘(元)
0.430.160.110.860.200.200.100.28-0.400.01
稀釋每股稅後盈餘(元)
0.420.160.110.860.200.200.100.28-0.390.01
基本平均股數(千股)
168836.00167827.00166808.00166535.00165974.00165551.00164798.00164812.00164234.00163458.00
稀釋平均股數(千股)
170650.00168681.00167668.00166696.00166178.00166174.00166623.00166510.00164234.00165046.00
還原基本每股稅後盈餘(元)
0.430.160.110.860.200.200.100.28-0.400.01
還原稀釋每股稅後盈餘(元)
0.420.160.110.860.200.200.100.28-0.390.01
還原基本平均股數(千股)
168,836167,827166,808166,535165,974165,551164,798164,812164,234163,458
還原稀釋平均股數(千股)
170,650168,681167,668166,696166,178166,174166,623166,510164,234165,046
EBITDA(千元)
46,44341,61028,614163,48238,62937,79924,74439,561-52,4166,618

大家都在看

HOT